Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Sell
45
CTAS Quote, Financials, Valuation and Earnings
Last price:
$207.90
Seasonality move
:
3.62%
Day range:
$204.28 - $208.20
52-week range:
$162.16 - $228.12
Dividend yield:
0.73%
P/E ratio:
48.15x
P/S ratio:
8.43x
P/B ratio:
18.27x
Volume:
1.6M
Avg. volume:
1.9M
1-year change:
22.18%
Market cap:
$83.9B
Revenue:
$9.6B
EPS (TTM):
$4.32
Cintas Number of Institutional Trades
Cintas Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$21.2B
(Last 6 Months)
Current Institutional Ownership Percentage
91.66%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$34.7B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Cintas Institutional Ownership
-
What Percentage Of CTAS Is Owned by Institutions?
91.66% of CTAS is owned by institutions.
-
How Many Institutions Own CTAS Shares?
Cintas stock is owned by 2,375 institutional shareholders at this time.
-
Have Institutions Been Buying CTAS Stock?
Yes, institutions have bought 68.2M shares of CTAS in the last quarter.
-
Have Institutions Been Selling CTAS Stock?
Yes, institutions have sold 102.3M shares of CTAS over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Too Late to Buy United Airlines Stock?
United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…
3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
GATE alert for Apr 2
Marblegate Acquisition [GATE] is up 86.64% over the past day.
Buy
52
NUTX alert for Apr 2
Nutex Health [NUTX] is up 5.41% over the past day.
Buy
75
CORT alert for Apr 2
Corcept Therapeutics [CORT] is down 8.84% over the past day.
